Pfizer, Inc. News Headlines

PFE 
$30.12
*  
0.23
 negative 
0.77%
Get PFE Alerts
*Delayed - data as of Apr. 16, 2014 10:13 ET 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PFE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 26, 2014
2/25/2014 10:00:03 AM - NASDAQ.com News

Pfizer Gets Good News For Pneumonia, Bone-Thinner Drugs
2/24/2014 6:12:00 PM - Investor's Business Daily

Oncology, Streamlined R&D Will Help Pfizer Going Forward
2/24/2014 2:43:45 PM - Trefis

Encouraging Data on Bristol-Myers/Pfizer's Eliquis - Analyst Blog
2/24/2014 12:50:01 PM - Zacks.com

Following The Latest In Alzheimer's Research As An Investor
2/24/2014 10:12:00 AM - Seeking Alpha

Pre-Market Most Active for Feb 24, 2014 : VZ, RFMD, TQNT, VOD, JOSB, BBRY, FB, PFE, BP, ALU, BAC, HUM
2/24/2014 9:39:53 AM - NASDAQ.com News

Sector Update: Healthcare Stocks Flat to Higher Pre-Market; Pfizer Lifts 4% on Positive Results for Prevenar Study
2/24/2014 9:25:32 AM - MT Newswires

Sector Update: Healthcare
2/24/2014 9:25:16 AM - MT Newswires

Pfizer Reports Positive Top-Line Results Of CAPiTA On Efficacy Of Prevenar 13
2/24/2014 8:28:00 AM - RTT News

Pfizer Pneumonia Vaccine Study Meets Clinical Objectives
2/24/2014 7:36:00 AM - Dow Jones Business News

Pfizer: CAPiTA Evaluating Prevenar 13 Meets Objectives - Quick Facts
2/24/2014 7:17:00 AM - RTT News

Pfizer Will Resume Shipping Thyroid Drug
2/21/2014 5:27:00 PM - Dow Jones Business News

The Way Forward As Merck Continues To Face Pricing And Competitive Pressure
2/21/2014 2:42:53 PM - Trefis

Quiet Period Expiration For Auspex Pharmaceuticals Could Boost Stock Even Higher
2/21/2014 1:24:00 PM - Seeking Alpha

Ligand Pharmaceuticals: 2014 Run Not Done With Short And Long-Term Catalysts Coming
2/21/2014 9:53:00 AM - Seeking Alpha

HealthSouth 16% February Upside Paced Healthcare Dogs
2/20/2014 4:44:00 PM - Seeking Alpha

XLV, KOLD: Big ETF Inflows
2/20/2014 2:00:15 PM - BNK Invest

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 21, 2014
2/20/2014 10:00:01 AM - NASDAQ.com News

Mexico's President Sends New Competition Bill to Congress
2/19/2014 5:09:00 PM - Dow Jones Business News

Dow Analyst Moves: PFE
2/19/2014 2:18:21 PM - BNK Invest

Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick
2/19/2014 1:03:13 PM - BNK Invest

Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for February 20, 2014
2/19/2014 10:00:01 AM - NASDAQ.com News

Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 19, 2014
2/18/2014 10:00:02 AM - NASDAQ.com News

GlaxoSmithKline PLC (GSK) Ex-Dividend Date Scheduled for February 19, 2014
2/18/2014 10:00:02 AM - NASDAQ.com News

Wall Street Winners: Were Analyst 2014 Picks Worth Their Salt?
2/18/2014 8:53:00 AM - Seeking Alpha